Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
360000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price)
Who receives how much
Shares delivered during the month: 360,000 shares (360,000 new shares; 0 treasury shares transferred)
EVO FUND (issued on 14 April 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥36–¥42. Details of the adjustment provisions and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 320,000; number exercised in March 2026: 3,600; number unexercised as of the end of March 2026: 32,000
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 14 April 2025 / Type 18th Stock Acquisition Rights with provisions for adjustment of the exercise price, allotted to EVO FUND / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 360,000 shares (360,000 new shares; 0 treasury shares transferred) |
| Intended allottee | EVO FUND (issued on 14 April 2025) |
| Total number of issued shares | 75,135,300 shares (as of the end of the month preceding the relevant month, including 31,656 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the month: ¥36–¥42. Details of the adjustment provisions and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 320,000; number exercised in March 2026: 3,600; number unexercised as of the end of March 2026: 32,000 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 14 April 2025 / Type 18th Stock Acquisition Rights with provisions for adjustment of the exercise price, allotted to EVO FUND / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.